Get your Inflammopharmacology paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.9
Authored by Sumalatha Gangadhar | Published on 17 August, 2026
Submitting to Inflammopharmacology goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Inflammopharmacology guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Inflammopharmacology. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Inflammopharmacology journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Inflammopharmacology guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Inflammopharmacology guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
| Element | Inflammopharmacology requirement |
|---|---|
| Abstract | Unstructured abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references. For life science journals (when applicable), trial registration number and date of registration should be included for prospectively registered trials, or followed by 'retrospectively registered' for retrospectively registered trials. No specific article type variations mentioned |
| Main text | Research papers: not longer than 8 printed pages (approximately 870 words or 4700 characters plain text without spaces per page, plus figures and tables counted separately; total ~6960 words excluding figures/tables). Brief Reports: preferably no more than 2 printed pages (~1740 words) with results and discussion combined. Reviews: not longer than 12 printed pages (~10,440 words). Comments, Correspondence, and Editorials (invited or contributed) also accepted but no specific word limits stated for these |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 4 to 6 keywords for indexing purposes |
| References | Author-date citation style (name and year in parentheses in text, e.g., Thompson 1990). Reference list should be alphabetized by last names of first author. Format follows standard Springer style with full author names, year, title, journal abbreviations per ISSN List of Title Word Abbreviations, volume, pages, and DOI links where available |
| Peer review | Single-blind peer review. All manuscripts are reviewed anonymously by at least two independent reviewers not connected with one another (as much as practicable). Reviewers' identities are not revealed to authors |
| Submission | submission.springernature.com/new-submission/10787/3 |
Read the Inflammopharmacology guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Inflammopharmacology in under a page.
Skim two or three recent Inflammopharmacology papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Inflammopharmacology journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Inflammopharmacology guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.